Login

Israel Englander is the founder and CEO of Millennium Management, a leading hedge fund in the USA. 00:10:00

Share On Facebook Share On Twitter

Israel Englander is Chairman and Chief Executive Officer of Millennium

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
AAC Technologies Group Publicity | Pan Zhengmin, CEO, AAC Technologies Holdings IncA2X:FRA
00:10:00
First Global Data: Empowering Financial Inclusion Through Innovation
00:10:00
Pride in Winning the IRB Trophy: A Team Achievement in Safety
00:00:00
Franck Mouthon, co-founder and CEO of Theranexus
00:10:00
Optimistic Outlook and Diversification Strategies | Paolo Gallo, CEO, Italgas SpA.
00:10:00
Federico 'Piki' Lopez, chairman and CEO of First Philippine Holdings Corp., emphasized the importance of sustainability and corporate responsibility.
00:00:00
Oliver Schacht, CEO, Curetis
00:00:00
Dr. Bennie Jeng, Cornea expert, Chair of the Department of Ophthalmology
00:10:00
Culture Rooted in Social Capital Drives Long-Term Success
00:10:00
Compañía Resources: Driving Gold Exploration Success in Namibia
00:10:00
Dan Williams, a financial planner, delivers a key message.
00:10:00
A Journey from Sri Lanka to U.S. Diplomacy|David Arulanantham

© 2017 - Neuhu+